Invention Grant
US07320992B2 Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use
有权
取代的2,3-二氢-1,5-异吲哚-1-酮衍生物及其使用方法
- Patent Title: Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use
- Patent Title (中): 取代的2,3-二氢-1,5-异吲哚-1-酮衍生物及其使用方法
-
Application No.: US10926238Application Date: 2004-08-24
-
Publication No.: US07320992B2Publication Date: 2008-01-22
- Inventor: Christopher Tegley , Jeffrey A. Adams , Benny C. Askew, Jr. , Michael Croghan , Daniel Elbaum , Julie Germain , Gregory J. Habgood , Scott Harried , Aiwen Li , Nobuko Nishimura , Rana Nomak , Andrew Tasker , Kevin Yang
- Applicant: Christopher Tegley , Jeffrey A. Adams , Benny C. Askew, Jr. , Michael Croghan , Daniel Elbaum , Julie Germain , Gregory J. Habgood , Scott Harried , Aiwen Li , Nobuko Nishimura , Rana Nomak , Andrew Tasker , Kevin Yang
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agent Joseph W. Bulock; Ronald S. Hermenau
- Main IPC: A61K31/4439
- IPC: A61K31/4439 ; C07D401/12
Abstract:
Selected compounds are effective for prophylaxis and treatment of diseases, such as angiogenesis mediated diseases. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving, cancer and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Public/Granted literature
- US20050054670A1 Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use Public/Granted day:2005-03-10
Information query
IPC分类:
